 | • レポートコード：GIR-23F3816 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Hematology Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の血液疾患治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 血液疾患治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・OTC、Rxドラッグ アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア、その他 世界の血液疾患治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Celgene、Pfizer、Roche、Sanof、Bristol-Myers Squibb、AbbVie、Novartis、GSK、Johnson & Johnson、Takeda 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 血液疾患治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：OTC、Rxドラッグ - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア、その他 - 世界の血液疾患治療薬市場規模・予測 - 世界の血液疾患治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Celgene、Pfizer、Roche、Sanof、Bristol-Myers Squibb、AbbVie、Novartis、GSK、Johnson & Johnson、Takeda ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：OTC、Rxドラッグ ・アプリケーション別分析2017年-2028年：病院、ドラッグストア、その他 ・血液疾患治療薬の北米市場分析 - 血液疾患治療薬の北米市場：タイプ別市場規模2017年-2028年 - 血液疾患治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・血液疾患治療薬のヨーロッパ市場分析 - ：血液疾患治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：血液疾患治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・血液疾患治療薬のアジア太平洋市場分析 - 血液疾患治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 血液疾患治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・血液疾患治療薬の南米市場分析 - 血液疾患治療薬の南米市場：タイプ別市場規模2017年-2028年 - 血液疾患治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・血液疾患治療薬の中東・アフリカ市場分析 - 血液疾患治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 血液疾患治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hematology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hematology Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Hematology Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While OTC segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hematology Drugs include Celgene, Pfizer, Roche, Sanof, and Bristol-Myers Squibb, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hematology Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
OTC
Rx Drugs
Market segment by Application can be divided into
Hospital
Drugs Store
Other
The key market players for global Hematology Drugs market are listed below:
Celgene
Pfizer
Roche
Sanof
Bristol-Myers Squibb
AbbVie
Novartis
GSK
Johnson & Johnson
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hematology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hematology Drugs, with price, sales, revenue and global market share of Hematology Drugs from 2019 to 2022.
Chapter 3, the Hematology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hematology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hematology Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hematology Drugs.
Chapter 13, 14, and 15, to describe Hematology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hematology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hematology Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Hematology Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Hematology Drugs Market Size & Forecast
1.4.1 Global Hematology Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Hematology Drugs Sales in Volume (2017-2028)
1.4.3 Global Hematology Drugs Price (2017-2028)
1.5 Global Hematology Drugs Production Capacity Analysis
1.5.1 Global Hematology Drugs Total Production Capacity (2017-2028)
1.5.2 Global Hematology Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hematology Drugs Market Drivers
1.6.2 Hematology Drugs Market Restraints
1.6.3 Hematology Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Celgene Details
2.1.2 Celgene Major Business
2.1.3 Celgene Hematology Drugs Product and Services
2.1.4 Celgene Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Hematology Drugs Product and Services
2.2.4 Pfizer Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Hematology Drugs Product and Services
2.3.4 Roche Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanof
2.4.1 Sanof Details
2.4.2 Sanof Major Business
2.4.3 Sanof Hematology Drugs Product and Services
2.4.4 Sanof Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Hematology Drugs Product and Services
2.5.4 Bristol-Myers Squibb Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Hematology Drugs Product and Services
2.6.4 AbbVie Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Hematology Drugs Product and Services
2.7.4 Novartis Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Hematology Drugs Product and Services
2.8.4 GSK Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Hematology Drugs Product and Services
2.9.4 Johnson & Johnson Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business
2.10.3 Takeda Hematology Drugs Product and Services
2.10.4 Takeda Hematology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hematology Drugs Breakdown Data by Manufacturer
3.1 Global Hematology Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Hematology Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Hematology Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Hematology Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Hematology Drugs Manufacturer Market Share in 2021
3.5 Global Hematology Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Hematology Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hematology Drugs Market Size by Region
4.1.1 Global Hematology Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Hematology Drugs Revenue by Region (2017-2028)
4.2 North America Hematology Drugs Revenue (2017-2028)
4.3 Europe Hematology Drugs Revenue (2017-2028)
4.4 Asia-Pacific Hematology Drugs Revenue (2017-2028)
4.5 South America Hematology Drugs Revenue (2017-2028)
4.6 Middle East and Africa Hematology Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Hematology Drugs Sales in Volume by Type (2017-2028)
5.2 Global Hematology Drugs Revenue by Type (2017-2028)
5.3 Global Hematology Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Hematology Drugs Sales in Volume by Application (2017-2028)
6.2 Global Hematology Drugs Revenue by Application (2017-2028)
6.3 Global Hematology Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Hematology Drugs Sales by Type (2017-2028)
7.2 North America Hematology Drugs Sales by Application (2017-2028)
7.3 North America Hematology Drugs Market Size by Country
7.3.1 North America Hematology Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Hematology Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Hematology Drugs Sales by Type (2017-2028)
8.2 Europe Hematology Drugs Sales by Application (2017-2028)
8.3 Europe Hematology Drugs Market Size by Country
8.3.1 Europe Hematology Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Hematology Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Hematology Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Hematology Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Hematology Drugs Market Size by Region
9.3.1 Asia-Pacific Hematology Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Hematology Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Hematology Drugs Sales by Type (2017-2028)
10.2 South America Hematology Drugs Sales by Application (2017-2028)
10.3 South America Hematology Drugs Market Size by Country
10.3.1 South America Hematology Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Hematology Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hematology Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Hematology Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Hematology Drugs Market Size by Country
11.3.1 Middle East & Africa Hematology Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Hematology Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Hematology Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Hematology Drugs
12.3 Hematology Drugs Production Process
12.4 Hematology Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Hematology Drugs Typical Distributors
13.3 Hematology Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Hematology Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Hematology Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Celgene Basic Information, Manufacturing Base and Competitors
Table 4. Celgene Major Business
Table 5. Celgene Hematology Drugs Product and Services
Table 6. Celgene Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Hematology Drugs Product and Services
Table 10. Pfizer Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Hematology Drugs Product and Services
Table 14. Roche Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanof Basic Information, Manufacturing Base and Competitors
Table 16. Sanof Major Business
Table 17. Sanof Hematology Drugs Product and Services
Table 18. Sanof Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Major Business
Table 21. Bristol-Myers Squibb Hematology Drugs Product and Services
Table 22. Bristol-Myers Squibb Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Hematology Drugs Product and Services
Table 26. AbbVie Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Hematology Drugs Product and Services
Table 30. Novartis Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GSK Basic Information, Manufacturing Base and Competitors
Table 32. GSK Major Business
Table 33. GSK Hematology Drugs Product and Services
Table 34. GSK Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson Hematology Drugs Product and Services
Table 38. Johnson & Johnson Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Takeda Basic Information, Manufacturing Base and Competitors
Table 40. Takeda Major Business
Table 41. Takeda Hematology Drugs Product and Services
Table 42. Takeda Hematology Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Hematology Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Hematology Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Hematology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Hematology Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Hematology Drugs Production Site of Key Manufacturer
Table 48. Hematology Drugs New Entrant and Capacity Expansion Plans
Table 49. Hematology Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Hematology Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Hematology Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Hematology Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Hematology Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Hematology Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Hematology Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Hematology Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Hematology Drugs Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Hematology Drugs Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Hematology Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Hematology Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Hematology Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Hematology Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Hematology Drugs Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Hematology Drugs Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Hematology Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Hematology Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Hematology Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Hematology Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Hematology Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Hematology Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Hematology Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Hematology Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Hematology Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Hematology Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Hematology Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Hematology Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Hematology Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Hematology Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Hematology Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Hematology Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Hematology Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Hematology Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Hematology Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Hematology Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Hematology Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Hematology Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Hematology Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Hematology Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Hematology Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Hematology Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Hematology Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Hematology Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Hematology Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Hematology Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Hematology Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Hematology Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Hematology Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Hematology Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Hematology Drugs Raw Material
Table 107. Key Manufacturers of Hematology Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Hematology Drugs Typical Distributors
Table 111. Hematology Drugs Typical Customers
List of Figures
Figure 1. Hematology Drugs Picture
Figure 2. Global Hematology Drugs Revenue Market Share by Type in 2021
Figure 3. OTC
Figure 4. Rx Drugs
Figure 5. Global Hematology Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drugs Store
Figure 8. Other
Figure 9. Global Hematology Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Hematology Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Hematology Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Hematology Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Hematology Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Hematology Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Hematology Drugs Market Drivers
Figure 16. Hematology Drugs Market Restraints
Figure 17. Hematology Drugs Market Trends
Figure 18. Global Hematology Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Hematology Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Hematology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Hematology Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Hematology Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Hematology Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Hematology Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Hematology Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Hematology Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Hematology Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Hematology Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Hematology Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Hematology Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Hematology Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Hematology Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Hematology Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Hematology Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Hematology Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Hematology Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Hematology Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Hematology Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Hematology Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Hematology Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Hematology Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Hematology Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Hematology Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Hematology Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Hematology Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Hematology Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Hematology Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Hematology Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Hematology Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Hematology Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Hematology Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Hematology Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Hematology Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Hematology Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Hematology Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Hematology Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Hematology Drugs in 2021
Figure 77. Manufacturing Process Analysis of Hematology Drugs
Figure 78. Hematology Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
| 【血液疾患治療薬について】 血液疾患治療薬は、様々な血液の病気や障害を治すために使用される薬剤群を指します。これらの薬剤は、特定の血液成分の異常や不足、またはそれらに関連する病理的状況に対処するために設計されています。血液疾患には、貧血、白血病、リンパ腫、血友病、血栓症、自己免疫性疾患などが含まれます。 血液疾患治療薬の特徴として、まずはその多様性が挙げられます。血液に影響を与える疾患は多岐に渡り、またそのメカニズムもさまざまです。そのため、治療薬は特定の疾患や症状に対応するために特化されていることが多いです。例えば、貧血治療薬は鉄剤やビタミンB12補充剤があり、白血病やリンパ腫の治療には化学療法剤や分子標的薬が利用されます。 さらに、これらの薬剤はその作用機序が異なります。例えば、抗がん剤は腫瘍細胞を攻撃することを目的としていますが、鉄剤は赤血球の生成を促進することで貧血を改善します。また、免疫抑制剤は自己免疫性疾患における過剰な免疫反応を抑えるために用いられます。このように、血液疾患治療薬は疾患の特性に応じて様々なメカニズムで機能します。 血液疾患治療薬の種類について考えると、さまざまなカテゴリーに分類されます。一つ目は、抗貧血薬です。これには鉄剤、ビタミンB12および葉酸の補充剤が含まれ、貧血の原因に応じて使用されます。次に、抗がん治療薬があります。これは白血病やリンパ腫に対して使用されるもので、化学療法、放射線療法、または新しい免疫療法が含まれます。そして、抗血栓薬も重要です。これには抗凝固薬や抗血小板薬が含まれ、血液の凝固を防ぐことで血栓症のリスクを低下させます。 血液疾患に関連する治療薬の用途は非常に広範です。貧血治療においては、鉄分補充療法が最も一般的で、特に鉄欠乏性貧血に対応します。これに対し、再生不良性貧血には骨髄刺激剤や免疫抑制剤が使用されることがあります。白血病やリンパ腫に関しては、対象とする細胞のタイプや進行度に応じて、さまざまな化学療法が用いられ、時には最近特に注目を集めているCAR-T細胞療法などの高度な治療技術も使用されます。 また、血栓症の治療では、抗凝固薬は深部静脈血栓症や肺塞栓症の予防・治療に使用されます。これにはワルファリンや新しい経口抗凝固薬（NOAC）が含まれ、患者の状態によって選択されます。さらに、自己免疫性疾患に対する治療では、免疫抑制薬や生物学的製剤が活用され、病気の進行を抑える働きをします。 最近の血液疾患治療薬の進展には、分子標的治療薬や免疫療法の革新があります。分子標的治療薬は、癌細胞の特定の遺伝子異常や病理機構に直接作用し、副作用を軽減しながら治療効果を得ることを目的としています。例えば、フィラデルフィア染色体陽性急性白血病（ Ph+ ALL）の治療には、チロシンキナーゼ阻害薬が用いられており、これにより高い治療成績が報告されています。 また、免疫療法も血液がんの治療において重要な役割を果たしています。CAR-T細胞療法に代表されるように、患者自身のT細胞を遺伝子改変して、特定の癌細胞を攻撃する力を高める手法が開発されています。これにより、従来の治療法では効果が不十分だった患者にも新たな治療の希望がもたらされています。 血液疾患治療薬の研究開発は、遺伝子治療や細胞治療といった新しい技術の進展により、ますます進化しています。これに伴い、個別化医療の観点から、患者ごとの遺伝的背景や病歴に基づいたオーダーメイドの治療が行われるようになっています。このように、血液疾患治療薬は常に進化しており、より効果的で安全な治療法の開発が期待されています。 以上のように、血液疾患治療薬は非常に多様で、それぞれの薬剤は特定の疾患や症状に対処するために設計されています。最新の技術を駆使した治療法の開発が進む中で、今後もさまざまな新しい治療選択肢が登場することが期待されます。これにより、多くの患者がより良い治療を受け、生活の質が向上することが望まれています。血液疾患治療薬は、今後も重要な役割を果たし続けることでしょう。 |
• 日本語訳：血液疾患治療薬のグローバル市場2022年
• レポートコード：GIR-23F3816 ▷ お問い合わせ（見積依頼・ご注文・質問）